NCPAP Decreases Cerebrovascular Risk in OSA Patients
Patients with sleep apnea having significantly higher serum levels of inflammatory markers, as well as lesions associated with silent brain infarction//, have an elevated risk of stroke, according to Japanese medical researchers. The results appear in the second issue for March 2007 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic S...NCP-2 External Counterpulsation Device
Description:With the launch of the NCP-2, ACS proudly introduces full disclosure to ECP Therapy. ACS has given physicians more tools for assessing the administration of ECP therapy through the first and only complete ECP Treatment Report.The ACS Treatment Report is a patent-pending, proprietary software program that allows both physicians and therapists to review patient progress throughout the course...NCP-1 External Counterpulsation Device
Description:The NCP-1, was designed to maximize patient comfort and deliver optimal treatment. The NCP-1 was the first ever to feature Vacuum Pump Deflation Technology. This proprietary technology helps maximize augmentation and reduces the "slamming" effect commonly associated with other systems. The high quality treatment platform maintains patients comfort and security while treatment is delivered. The NC...